Evidence map›Paper›PMID 25074923›Full record

ArticleThe Journal of biological chemistry2014

Activation of the double-stranded RNA-dependent protein kinase PKR by small ubiquitin-like modifier (SUMO).

Carlos F de la Cruz-Herrera, Michela Campagna, Maria A García, Laura Marcos-Villar, Valerie Lang, Maite Baz-Martínez, Sylvia Gutiérrez, Anxo Vidal, Manuel S Rodríguez, Mariano Esteban and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. RNA recognition by PKR during DNA virus infection.Journal of medical virology · 2024
    Review
  7. Review
  8. Review
  9. Inhibition of PKR by Viruses.Frontiers in microbiology · 2021
    Review
  10. Article
  11. SUMO and Cytoplasmic RNA Viruses: From Enemies to Best Friends.Advances in experimental medicine and biology · 2020
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Carlos F de la Cruz-HerreraDepartamento de Biología Molecular y Celular, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CSIC), Darwin 3, Madrid 28049.
Michela CampagnaDepartamento de Biología Molecular y Celular, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CSIC), Darwin 3, Madrid 28049.
Maria A GarcíaUnidad de Investigación, Hospital Universitario Virgen de las Nieves, 18014 Granada.
Laura Marcos-VillarDepartamento de Biología Molecular y Celular, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CSIC), Darwin 3, Madrid 28049.
Valerie LangUbiquitylation and Cancer Molecular Biology Laboratory, Inbiomed, San Sebastian-Donostia, 20009 Gipuzkoa, Spain.
Maite Baz-MartínezCentro de Investigación en Medicina Molecular (CIMUS), Universidade de Santiago de Compostela, Instituto de Investigaciones Sanitarias (IDIS), Santiago de Compostela E15782.
Sylvia GutiérrezConfocal Service of Centro Nacional de Biotecnología-CSIC, Darwin 3, Madrid 28049, and.
Anxo VidalDepartamento de Fisioloxía and Centro de Investigación en Medicina Molecular (CIMUS), Universidade de Santiago de Compostela, Instituto de Investigaciones Sanitarias (IDIS), Santiago de Compostela E15782, Spain.
Manuel S RodríguezUbiquitylation and Cancer Molecular Biology Laboratory, Inbiomed, San Sebastian-Donostia, 20009 Gipuzkoa, Spain.
Mariano EstebanDepartamento de Biología Molecular y Celular, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CSIC), Darwin 3, Madrid 28049.
Carmen RivasDepartamento de Biología Molecular y Celular, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CSIC), Darwin 3, Madrid 28049,; Centro de Investigación en Medicina Molecular (CIMUS), Universidade de Santiago de Compostela, Instituto de Investigaciones Sanitarias (IDIS), Santiago de Compostela E15782,. Electronic address: crivas@cnb.csic.es.
Centro Nacional de Biotecnología · ESHospital Universitario Virgen de las Nieves · ESInstituto de Investigación Sanitaria de Santiago · ESUniversidade de Santiago de Compostela · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The dsRNA-dependent kinase PKR is an interferon-inducible protein with ability to phosphorylate the α subunit of the eukaryotic initiation factor (eIF)-2 complex, resulting in a shut-off of general translation, induction of apoptosis, and inhibition of virus replication. Here we analyzed the modification of PKR by the small ubiquitin-like modifiers SUMO1 and SUMO2 and evaluated the consequences of PKR SUMOylation. Our results indicate that PKR is modified by both SUMO1 and SUMO2, in vitro and in vivo. We identified lysine residues Lys-60, Lys-150, and Lys-440 as SUMOylation sites in PKR. We show that SUMO is required for efficient PKR-dsRNA binding, PKR dimerization, and eIF2α phosphorylation. Furthermore, we demonstrate that SUMO potentiates the inhibition of protein synthesis induced by PKR in response to dsRNA, whereas a PKR SUMOylation mutant is impaired in its ability to inhibit protein synthesis and shows reduced capability to control vesicular stomatitis virus replication and to induce apoptosis in response to vesicular stomatitis virus infection. In summary, our data demonstrate the important role of SUMO in processes mediated by the activation of PKR.

Indexed as

Sumoylation3T3 CellsAnimalseIF-2 KinaseEnzyme ActivationHost-Pathogen InteractionsImmunity, InnateMicePeptide MappingProtein BindingProtein MultimerizationRNA, Double-StrandedRNA, ViralSequence Analysis, ProteinSUMO-1 ProteinVesiculoviruseIF-2 KinaseRNA, Double-StrandedRNA, ViralSUMO-1 ProteinSUMO1 protein, humanDouble-stranded RNA (dsRNA)Protein Kinase RNA-activated (PKR)SumoylationTranslation ControlVirus

Identifiers

PMID25074923
PMCPMC4176227
OpenAlexW1992742103

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.